[ORGANIZATION]
Zealand Pharma
Featured in 3 tracked stories · first seen
Situations
Clinical developments in obesity and diabetes medications
2 clusters · 12 sources · last updated
Latest: Zealand Pharma reports positive Phase 2 results for obesity drug petrelintide
Pharmaceutical developments regarding experimental treatments for obesity and type 2 diabetes have shown positive results in Phase II clinical trials. In late September 2026, Roche and Genentech reported successful Phas
Medical research in metabolic and liver diseases
2 clusters · 5 sources · last updated
Latest: Medical research advances in liver disease and obesity treatments
Medical research has identified new potential pathways for treating metabolic diseases, specifically focusing on liver health and obesity. Researchers at Cedars-Sinai have identified the UBE2N enzyme as a potential targ
Also covered in
-
Goldman Sachs and Roche face key market developments
[BUSINESS] · 2 sources ·